CTT Pharmaceutical Holdings, Inc. CTTH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | -76.29% | 228.76% | -41.52% | ||
| Depreciation & Amortization | 6.25% | 6.25% | 0.00% | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | -72.46% | 214.46% | -37.55% | ||
| Operating Income | 72.46% | -214.46% | 37.55% | ||
| Income Before Tax | 66.30% | -187.12% | -7.25% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 66.30% | -187.12% | -7.25% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 66.30% | -187.12% | -7.25% | ||
| EBIT | 72.46% | -214.46% | 37.55% | ||
| EBITDA | 76.29% | -228.76% | 38.59% | ||
| EPS Basic | 62.50% | -180.00% | 0.00% | ||
| Normalized Basic EPS | 60.00% | -200.00% | 16.67% | ||
| EPS Diluted | 62.50% | -180.00% | 0.00% | ||
| Normalized Diluted EPS | 60.00% | -200.00% | 16.67% | ||
| Average Basic Shares Outstanding | 3.10% | 5.20% | 10.57% | ||
| Average Diluted Shares Outstanding | 3.10% | 5.20% | 10.57% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||